ISBN: 978-93-87500-70-9
Open Access eBooks is inviting researchers working in the areas of Type 2 Diabetes to submit their book chapter for the publication in volume 1 of an eBook entitled An eBook on Type 2 Diabetes
All book chapters undergo review process and published content is available in PDF & HTML formats.
Benefits of publishing with us:
Universal Access: eBooks published in Open Access eBooks gain international visibility. No region barriers and content is accessed by everyone across the world from our website. We also deposit published eBooks in different databases.
Freely Available: Open Access eBooks follows the principles of Open Access and the content is available to the readers without any cost. Readers can read, share, and store the published ebooks/book chapters.
Copyright with Authors: As an eBook publisher, we serve researchers in publishing their valuable work after the stringent review process. However, copyright lies with authors. We follow the CC-BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/3.0/).
Different Formats: We provide eBooks in PDF and HTML formats. Both formats are user friendly and can act as per the user requirements. We put our efforts to provide other formats in future.
For more information, contact info@openaccessebooks.com
Published Chapters:
Nonalcoholic Fatty Liver Disease in Diabetes: From Diagnosis to Treatment
Author(s): Athanasia K Papazafiropoulou*; Eleni Xourgia; Andreas Melidonis
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of elevated liver enzymes and chronic liver disease, affecting approximately 30% of the general population. NAFLD involves the presence of hepatic steatosis not caused by alcohol intake. In NAFLD, the histological examination of liver biopsy reveals excess accumulation of lipids (representing predominantly triglycerides) within hepatocytes. NAFLD may progress from steatosis to steatohepatitis, cirrhosis, and finally liver failure.
Lifestyle Intervention and Type 2 Diabetes
Author(s): Carlos Vasconcelos
This review aimed to evaluate, through randomized controlled trials, the effects of lifestyle interventions on the evolution of cardiovascular risk factors in adult patients with type 2 diabetes. An electronic search was performed in PubMed and list of references from 2016 until May 2021 was made. Studies were eligible if 1) participants had type 2 diabetes; 2) mean age < 65 years old; 3) at least 3 cardiovascular risk factors measured before and after lifestyle intervention; 4) the study design was a randomized controlled trial.
